Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. - Wikidata - wikimedia - TriplyDB

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

http://www.wikidata.org/entity/Q27472922

about

The role of viral persistence in flavivirus biology Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Usutu virus: an emerging flavivirus in Europe Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease Structure of yellow fever virus envelope protein domain III Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex Stereophysicochemical variability plots highlight conserved antigenic areas in Flaviviruses Peptide inhibitors of dengue virus and West Nile virus infectivity Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine Nonviremic transmission of West Nile virus Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion Crystal Structure of the West Nile Virus Envelope Glycoprotein Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein Monoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse Sera Preparation and immunogenic properties of a recombinant West Nile subunit vaccine Sensitivity and specificity of monoclonal and polyclonal immunohistochemical staining for West Nile virus in various organs from American crows (Corvus brachyrhynchos)Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition Genetically delivered antibody protects against West Nile virus Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II Closing the door on flaviviruses: Entry as a target for antiviral drug design The structural immunology of antibody protection against West Nile virus The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus Progress on the development of therapeutics against West Nile virus Effector Functions of Camelid Heavy-Chain Antibodies in Immunity to West Nile Virus Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

P2860

Q22809893-9F3796C5-4E26-480F-86E5-2C22653BF4DF Q23925011-8C5189C0-B85F-4D3D-ACCB-74FB1C51321F Q24273302-57B02E25-AC41-4C57-890E-352B43F72824 Q24273313-C4B00B21-077E-4055-AB22-68A90BCE3E75 Q24289393-9CA782E7-6012-4632-8248-CD0FE0EFCD26 Q24737461-76C343F0-068F-4080-BE54-96F15EFD557A Q24804265-2A228309-8DE1-456C-9CC2-BFC003FDE215 Q24813811-70094A45-FB36-4794-BBAE-4A276244BA4D Q26700097-96304FE8-765A-45EE-A92D-A71B35A2A183 Q26782367-22B95047-96DC-436B-9266-6BDB81DD1D47 Q27469992-2CC5FE4D-B5A0-4247-833F-7CEB7CF0B66C Q27473186-45805114-6037-4863-872C-A6F9AEBCB1DB Q27473288-E01EF41C-DAF8-4966-8979-E15D64B7A00E Q27477479-DFC37334-CCC3-40B4-94B5-7F85BCC6D853 Q27477543-318B830F-E126-4CFF-94F4-2E7EC59238D8 Q27477648-133F4397-1772-48B4-A9E9-50CF7841C2BC Q27477718-EF4080D3-1A7C-4D05-A068-05F054193507 Q27478079-E187F139-E4B0-47E4-9417-D39CDBAECC3D Q27478202-2A37A4EB-8F04-47F1-8AD2-624DE0A1470F Q27480292-16A69D90-2ED0-4CF1-B3C2-13897DA0C2E3 Q27481420-7FFA6087-6CBA-494E-A689-B731058AD731 Q27484980-87C9D85F-A862-4910-AD55-566A1AF94552 Q27485031-F845A62C-C5B4-4569-B294-985A0969450B Q27485383-BC207620-F102-4969-864D-78FE4472FA89 Q27485481-BAB46F9D-7768-4940-93EE-C1182FF86CAC Q27485890-F11F713F-A272-4399-A29A-B1C6C1BDD729 Q27486409-C2936676-D8C3-4F9D-AE90-26768B7DE0DD Q27487953-0867B04C-F238-41C3-9C35-F92D323D82B0 Q27487955-DA4EA409-FC92-4FB7-B865-CF7AEC42AB00 Q27488224-E9AB3DE4-C9CD-47E0-867A-B3DFFB590013 Q27488337-F1B7E410-4640-4619-AFC2-291EC94AE62D Q27488791-5FD4CB3C-E392-4460-B72C-3C7467F31DE3 Q27489620-5EB99A51-24D5-4034-BA98-C6B9BDB54E01 Q27489782-1EB7FF75-AB1F-4641-AA79-9C607CC9083E Q27489893-799B7999-252C-4616-BFD8-E6060EBF088E Q27490881-E3DD9A3A-6C99-4AC9-A724-1F9825D74079 Q27491049-25D9B624-A305-4EB7-A896-0E537CAAAB1B Q27491299-FDA8C1B4-586C-43C1-A38A-30B596AD0A88 Q27491317-C71FEFB9-3A89-48AD-82CC-3A1A8C2CBC32 Q27642288-A9BB1575-9719-451F-8D81-F8A9850C78F3

P2860

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

http://www.wikidata.org/entity/Q27472922

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Identification of Neutralizing ...... st Nile Virus Envelope Protein

@nl

Identification of neutralizing ...... t Nile virus envelope protein.

@ast

Identification of neutralizing ...... t Nile virus envelope protein.

@en

type

label

Identification of Neutralizing ...... st Nile Virus Envelope Protein

@nl

Identification of neutralizing ...... t Nile virus envelope protein.

@ast

Identification of neutralizing ...... t Nile virus envelope protein.

@en

prefLabel

Identification of Neutralizing ...... st Nile Virus Envelope Protein

@nl

Identification of neutralizing ...... t Nile virus envelope protein.

@ast

Identification of neutralizing ...... t Nile virus envelope protein.

@en

P1433

Q27472922-48410069-047D-4718-9973-6C39DB2E295A

P1476

Q27472922-21FD8CDB-F78D-46D2-9D92-88F8E41989A2

P2860

Q27472922-04E80287-3B65-490C-ABC2-269D24BF9E92

Q27472922-0C801022-F290-430C-9DFB-0CF9647E7F88

Q27472922-159CE4AF-3F64-4978-B832-8D98C48A6E5E

Q27472922-41683FF3-4986-4D47-A8D1-39F26A5185DE

Q27472922-474034BB-A33A-4AAC-9986-378EDE5DE5BC

Q27472922-5A123040-7AE9-4991-B2BB-3A989A740CB4

Q27472922-5BB8E5B5-FBE0-4C10-868F-5B66916180E1

Q27472922-668B01E7-B660-44BD-83EB-E2CD688B4E03

Q27472922-7112AC56-9732-4699-B78C-497FC37AFF68

Q27472922-7F2E1DE6-7DAF-45FE-9D37-21C4DF2CE25F

P304

Q27472922-A946C125-49B3-4715-9B3A-E56D9AACE398

P31

Q27472922-72645521-93D4-4421-93F1-81BED228CFF5

P3181

Q27472922-3278D8B2-43A4-4A66-BB89-7854A4979A37

P356

Q27472922-F0D9E88B-D82F-4A83-9672-C23133A8CE52

P433

Q27472922-8BEED27F-78EA-4F49-A960-554266285963

P478

Q27472922-78B60D06-ECAA-40F3-8C57-32DB20B2443D

P50

Q27472922-4A50BF4F-8F9A-4644-811F-1B24131BC2B7

Q27472922-B0B371FF-D431-4FED-9A20-AF28E301E7CC

P577

Q27472922-44DDFD1D-F703-41E6-B482-BEDF19D05A9F

P698

Q27472922-8951E322-0F31-4CEA-B920-0A7334631C63

P921

Q27472922-186F4C66-4B0C-4004-97D5-3C349987D795

P932

Q27472922-C80EB9AE-C8DD-4408-95AB-F4886D000D27

P3181

P356

JVI.76.24.13097-13100.2002

P1433

Journal of Virology

P1476

Identification of neutralizing ...... t Nile virus envelope protein.

@en

P2860

West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections.

West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations.

P304

13097-13100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4555702

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.76.24.13097-13100.2002

http://www.w3.org/2001/XMLSchema#string

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Alan D T Barrett

David W C Beasley

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12438639

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

136710

http://www.w3.org/2001/XMLSchema#string